Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine

Critical Care Medicine

Volumn 31, Issue 1 SUPPL., 2003, Pages

  Salvemini, Daniela ^a   Cuzzocrea, Salvatore ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Ischemia reperfusion injury; Oxidative stress; Oxygen derived free radicals; Superoxide dismutase mimetics

Indexed keywords

ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; DNA; EUKI 134; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEMATOPORPHYRIN MANGANESE; M 40401; MACROCYCLIC COMPOUND; MANGANESE; MANGANESE DERIVATIVE; MANGANESE N,N' ETHYLENEBIS(3 METHOXYSALICYLIDENEAMINE); MANGANESE SALEN CHLORIDE; MANGANESE SALEN COMPLEX; MANGANESE SUPEROXIDE DISMUTASE; MANGANESEDICHLORO(3,10,13,20,26 PENTAAZATETRACYCLO[20.3.1.0(4,9).0(14,19)] 1(26),22(23),24 HEXACOSATRIENE); MEMBRANE PROTEIN; MITOCHONDRIAL ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SEROTONIN; SODIUM CHANNEL; SUPEROXIDE DISMUTASE; THROMBOXANE A2; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT;

ANTIOXIDANT ACTIVITY; CELL DAMAGE; CYTOTOXICITY; DISEASE SEVERITY; DNA STRAND BREAKAGE; ENDOTHELIUM INJURY; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; HUMAN; INTENSIVE CARE; ISCHEMIA; LIPID PEROXIDATION; NONHUMAN; OXIDATION KINETICS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; REPERFUSION; REVIEW; SEPTIC SHOCK; SHOCK; TREATMENT FAILURE;

EID: 0037251347     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200301001-00005     Document Type: Review

References (151)

1. Morpurgo E, Cadrobbi R, Morpurgo M, et al: Protective effect of superoxide dismutase and polyethylene glycol-linked superoxide dismutase against renal warm ischemia/reperfusion injury. Transplantation 1996; 62:1221-1223
2. Yoshikawa T, Naito Y, Ueda S, et al: Ischemia-reperfusion injury and free radical involvement in gastric mucosal disorders. Adv Exp Med Biol 1990; 264:401-410
3. Zimmerman BJ, Arndt H, Kubes P, et al: Reperfusion injury in the small intestine. In: Pathophysiology of Shock, Sepsis, and Organ Failure. Schlag G, Red H (Eds). Berlin, Springer-Verlag, 1993, pp 322-335
4. Salvemini D, Riley DP, Lennon PJ, et al: Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage. Br J Pharmacol 1999; 127:685-692
5. Salvemini D, Wang ZQ, Zweier JL, et al: A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science 1999; 286:304-306
6. Cuzzocrea S, Mazzon E, Dugo L, et al: Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion. Br J Pharmacol 2001; 132:19-29
7. Goossens DP, Rao VK, Harms BA, et al: Superoxide dismutase and catalase in skin flaps during venous occlusion and reperfusion. Ann Plast Surg 1990; 25:21-25
8. Ambrosio G, Flaherty JT: Effects of the superoxide radical scavenger superoxide dismutase, and of the hydroxyl radical scavenger mannitol, on reperfusion injury in isolated rabbit hearts, Cardiovasc Drugs Ther 1992; 6:623-632
9. Grill HP, Zweier JL, Kuppusamy P, et al: Direct measurement of myocardial free radical generation in an in vivo model: Effects of postischemic reperfusion and treatment with human recombinant superoxide dismutase. J Am Coll Cardiol 1992; 20:1604-1611
10. McCord JM, Fridovich I: Superoxide dismutase: An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244:6049-6055
11. Reaume AG, Elliott JT, Hoffman EK, et al: Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury, Nat Genet 1996; 13:43-47
12. Carlsson LM, Jonsson J, Edlundand T, et al: Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci U S A 1995; 92:6264-6268
13. Li Y, Huang TT, Carlson EJ, et al: Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995; 11:376-381
14. Melov S, Coskun P, Patel M, et al: Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A 1999; 96:846-851
15. Ho YS, Vincent R, Dey MS, et al: Transgenic models for the study of lung antioxidant defense: Enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am J Respir Cell Mol Biol 1998; 18:538-547
16. Sohal RS, Agarwal A, Agarwal S, et al: Simultaneous overexpression of copper- and zinc-containing superoxide dismutase and catalase retards age-related oxidative damage and increases metabolic potential in Drosophila melanogaster. J Biol Chem 1995; 270:15671-15674
17. Halliwell B, Gutteridge JMC: Free radicals in biology and medicine. In: Molecular Aspects of Medicine. Baum H, Gergely J, Fanburg BL (Eds.) New York, Oxford University Press, 1985, pp 89-193
18. Mc Cord JM: Free radicals and inflammation: Protection of synovial fluid by superoxide dismutase. Science 1974; 185:529-531
19. McCord JM: Superoxide dismutase: Rationale for use in reperfusion injury and inflammation. J Free Rad Biol Med 1986; 2:307-310
20. Burton KP: Superoxide dismutase enhances recovery following myocardial ischemia. Am J Physiol 1985; 248:H637-H643
21. Li Q, Bolli R, Qiu Y, et al: Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation 2001; 103:1893-1898
22. Ma XL, Johnson G III, Lefer AM: Low doses of superoxide dismutase and a stable prostacyclin analogue protect in myocardial ischemia and reperfusion. J Am Coll Cardiol 1992; 19:197-204
23. Chen Z, Oberley TD, Ho Y, et al: Overexpression of CuZnSOD in coronary vascular cells attenuates myocardial ischemia/reperfusion injury. Free Radic Biol Med 2000; 29:589-596
24. Zweier JL: Prevention of reperfusion-induced, free radical-mediated acute endothelial injury by super oxide dismutase as an effective tool to delay/prevent chronic renal allograft failure: A review. Transplant Proc 1997; 29:2567-2568
25. Shingu M, Takahashi S, Ito M, et al; Anti-inflammatory effects of recombinant human manganese superoxide dismutase on adjuvant arthritis in rats, Rheumatol Int 1994; 14:77-81
26. Oyanagui Y: Participation of superoxide anions at the prostaglandin phase of carrageenan foot-oedema. Biochem Pharmacol 1976; 25:1465-1472
27. Klivenyi P, St Clair D, Wermer M, et al: Manganese superoxide dismutase overexpression attenuates MPTP toxicity. Neurobiol Dis 1998 5:253-258
28. Bravard A, Sabatier L, Hoffschir F, et al: SOD2: A new type of tumor-suppressor gene? Int J Cancer 1992; 51:476-480
29. Church SL, Grant JW, Ridenour LA, et al: Increased manganese superoxide dismutase expression suppresses the malignant human melanoma cells. Proc Natl Acad Sci U S A 1993; 90:3113-3117
30. Safford SE, Oberley TD, Urano M, et al: Suppression of fibrosarcoma metastasis by elevated expression of manganese dismutase. Cancer Res 1994; 54:4261-4265
31. Edas MA, Emerit I, Khalhoun Y, et al: Clastogenic factors in plasma of HIV-1 infected patients activate HIV-1 replication in vitro: Inhibition by superoxide dismutase. Free Rad Biol Med 1997; 23:571-578
32. Mollace V, Nottet HS, Clayette P, et al: Oxidative stress and neuroAIDS: Triggers, modulators and novel antioxidants. Trends Neurosci 2001; 24:411-416
33. Salminen U, Harjula AL, Maasilta PK, et al: Superoxide dismutase in development of obliterative bronchiolitis. Transplant Proc 2001; 33:2477
34. Barnes JP: Chronic obstructive pulmonary disease. Med Prog 2000; 343:269-280
35. Wengenack TM, Curran GL, Poduslo JF: Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia. Brain Res 1997; 754:46-54
36. Przedborski S, Kostic V, Jackson-Lewis V, et al: Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci 1992; 12:1658-1667
37. Flohe L: Superoxide dismutase for therapeutic use: Clinical experience, dead ends and hopes. Mol Cell Biochem 1988; 84:123-131
38. Babior BM: Superoxide: A two-edged sword. Braz J Med Biol Res 1982; 30:141-155
39. Salvemini D, Riley DP: M40403. Drugs Future 2000; 25:1027-1033
40. Riley DP: Synthesis, characterization and stability of manganese (ii) c-substituted 1,4,7,10,13-pentaazacyclopentadecane complexes exhibiting superoxide dismutase activity. Inorg Chem 1996; 35:5213-5231
41. Riley DP, Lennon PJ, Neumann WL, et al: Toward the rational design of superoxide dismutase mimics: Mechanistic studies for the elucidation of substituent effects on the catalysis activity of macrocyclic manganese (ii) complexes. J Am Chem Sac 1997; 119:6522
42. Day BJ, Shawen S, Liochev SI, et al: A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced endothelial cell injury, in vitro. J Pharmacol Exp Ther 1995; 275:1227-1232
43. Day BJ, Fridovich I, Crapo JD: Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. Arch Biochem Biophys 1997; 347:256-262
44. Day BJ, Batinic-Haberle J, Crapo JD: Metalloporphyrins are potent inhibitors of lipid peroxidation. Free Radic Biol Med 1999; 26:730-736
45. Faulkner KM, Liochev SI, Fridovich I: Stable Mn(III) porphyrins mimic superoxide dismutase in vitro and substitute for it in vivo. J Biol Chem 1994; 269:23471-23476
46. Szabó C, Day BJ, Salzman AL: Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages, using a novel mesoporphyrin superoxide dismutase analog and peroxynitrite scavenger. FEBS Lett 1996; 381:82-86
47. Gardner PR, Nguyen DD, White CW: Superoxide scavenging by Mn(II/III) tetrakis (1-methyl-4-pyridyl) porphyrin in mammalian cells. Arch Biochem Biophys 1996; 325:20-28
48. Crow JP: Peroxynitrite scavenging by metalloporphyrins and thiolates. Free Radic Biol Med 2000; 28:1487-1494
49. Zingarelli B, Day BJ, Crapo JD, et al: The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol 1997; 120:259-267
50. Szabo C: Potential role of the peroxynitratepoly(ADP-ribose) synthetase pathway in a rat model of severe hemorrhagic shock. Shock 1998; 9:341-344
51. Malassagne B, Ferret PJ, Hammoud R, et al: The superoxide dismutase mimetic MnT-BAP prevents Fas-induced acute liver failure in the mouse. Gastroenterology 2001; 121:1451-1459
52. Ferret PJ, Hammoud R, Tulliez M, et al: Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. Hepatology 2001; 33:1173-1180
53. Doctrow SR, Huffman K, Marcus CB, et al: Salen-manganese complexes: Combined superoxide dismutase/catalase mimics with broad pharmacological efficacy. Adv Pharmacol 1997; 38:247-269
54. Malfroy B, Doctrow SR, Orr PL, et al: Prevention and suppression of autoimmune encephalomyelitis by EUK-8, a synthetic catalytic scavenger of oxygen-reactive metabolites. Cell Immunol 1997; 177:62-68
55. Baker K, Marcus CB, Huffman K, et al: Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: A key role for reactive oxygen species in ischemic brain injury. J Pharmacol Exp Ther 1998; 284:215-221
56. Bianca R, Wayman N, McDonald M, et al: Superoxide dismutase mimetic with catalase activity, EUK-134, attenuates the multiple organ injury and dysfunction caused by endotoxin in the rat. Med Sci Monit 2002; 8:BR1-BR7
57. Gonzalez PK, Zhuang J, Doctrow SR, et al: EUK-8, a synthetic superoxide dismutase and catalase mimetic, ameliorates acute lung injury in endotoxemic swine. J Pharmacol Exp Ther 1995; 275:798-806
58. Salvemini D, Mazzon E, Dugo L, et al: Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403. Br J Pharmacol 2001; 132:815-827
59. Salvemini D, et al: M40403, a superoxide dismutase mimetic, ameliorates joint disease in a rat model of collagen-induced arthritis. Arthritis Rheum 2001; 44:2909-2922
60. Centers for Disease Control and Prevention, National Center for Health Statistics: Mortality patterns: United States, 1990. Monthly Vital Stat Report 1993; 41:45
61. American College of Chest Physicians, Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-875
62. De Warra I, Jaccard C, Corradin SB, et al: Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997; 25:607-613
63. Siegel JH, Greenspan M, Del Guercio LRM: Abnormal vascular tone, defective oxygen transport, and myocardial failure in human septic shock. Ann Surg 1967; 165:504-551
64. Macarthur H, Westfall TC, Riley DP, et al: Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci U S A 2000; 97:9753-9758
65. Macarthur H, Couri DM, Wilken GH. et al: Modulation of serum cytokine levels by a novel superoxide dismutase mimetic, M40401, in an E. coli model of septic shock: Correlation with preserved circulating catecholamines. In Press
66. Groeneveld ABJ, Bronsveld W, Thijs LG: Hemodynamic determinants of mortality in human septic shock. Surgery 1986; 99:140-152
67. Levy B, Bollaert PE, Charpentier C, et al: Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective, randomized study. Intensive Care Med 1997; 23:282-287
68. Martin C, Viviand X, Leone M, et al: Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28:2758-2765
69. Thiemermann C: The role of the L-arginine: Nitric oxide pathway in circulatory shock. Adv Pharmacol 1994; 28:45-79
70. Taylor DE, Ghio AJ, Piantadosi CA: Reactive oxygen species produced by liver mitochondria of rats in sepsis. Arch Biochem Biophys 1995; 316:70-76
71. Thiemermann C, Vane J: Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 1990; 182:591-595
72. Parratt JR: Nitric oxide: A key mediator in sepsis and endotoxaemia. J Physiol Pharmacol 1997; 48:493-506
73. Wray GM, Millar CG, Hinds CJ, et al: Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock 1998; 9:329-335
74. Nicholson SC, Grobmyer SR, Shiloh MU, et al: Lethality of endotoxin in mice genetically deficient in the respiratory burst oxidase, inducible nitric oxide synthase, or both. Shock 1999; 11:253-258
75. Boughton-Smith NK, Evans SM, Laszlo F, et al: The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 1993; 110:1189-1195
76. Fantone JC, Ward PA: A review: Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 1982; 107:395-418
77. Deitch EA, Bridges W, Berg R, et al: Hemorrhagic shock-induced bacterial translocation: The role of neutrophils and hydroxyl radicals. J Trauma 1990; 30:942-951
78. Dix TA, Hess KM, Medina MA, et al: Mechanism of site-selective DNA nicking by the hydrodioxyl (perhydroxyl) radical. Biochemistry 1996; 35:4578-4583
79. 2+. Inflamm Res 1999; 48:544-549
80. 38 kinase activation modulates E. coli endotoxin-induced cytokine production in alveolar macrophages. Am J Respir Crit Care Med 2002; 165:A618
81. Schreck R, Riber P, Bauerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991; 10:2247-2258
82. Macmillan-Crow LA, Thompson JA: Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite. Arch Biochem Biophys 1999; 66:82-88
83. Szabó C, Dawson VL: Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 1999; 19:287-298
84. Karoui H, Hogg N, Frejaville C, et al: Characterization of sulfur-centered radical intermediates formed during the oxidation of thiols and sulfite by peroxynitrite: ESR-spin trapping and oxygen uptake studies. J Biol Chem 1996; 271:6000-6009
85. Vatassery GT: Oxidation of vitamin E, vitamin C, and thiols in rat brain synaptosomes by peroxynitrite. Biochem Pharmacol 1996; 52:579-586
86. Szabó C, Zingarelli B, Salzman AL: Role of poly-ADP ribosyltransferase activation in the nitric oxide- and peroxynitrite-induced vascular failure. Circ Res 1996; 78:1051-1063
87. Van der Vliet A, Smith D, O'Neill CA, et al: Interactions of peroxynitrite with human plasma and its constituents: Oxidative damage and antioxidant depletion. Biochem J 1994; 303:295-301
88. Phelps DT, Ferro TJ, Higgins PJ, et al: TNF-alpha induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. Am J Physiol 1995; 269:L551-L559
89. Cuzzocrea S, Zingarelli B, O'Connor M, et al: Effect of L-buthionine-(S,R)-sulphoximine, an inhibitor of gamma-glutamylcysteine synthetase on peroxynitrite- and endotoxic shock-induced vascular failure. Br J Pharmacol 1998; 123:525-537
90. Morris PE, Wheeler AP, Meyrick, Bernard GR: Escherichia coli endotoxin-mediated endothelial injury is modulated by glutathione ethyl ester. J infect Dis 1995; 172:1119-1122
91. van der Poll T, Coyle SM, Barbosa K, et al: Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996; 97:713-719
92. Guirao X, Kumar A, Katz J, et al: Catecholamines increase monocyte TNF receptors and inhibit TNF through β2-adrenoceptor activation. Am J Physiol 1997; 273: E1203-E1208
93. Le Tulzo Y, Shenkar R, Kaneko D, et al: Hemorrhage increases cytokine expression in lung mononuclear cells in mice: Involvement of catecholamines in nuclear factor κ-B regulation and cytokine expression. J Clin Invest 1997; 99:1516-1524
94. Shenkar R, Yum HK, Arcaroli J, et al: Interactions between CPB, NF-κB and CREB in the lungs after hemorrhage and endotoxemia. Am J Physiol 2001; 281:L418-L426
95. Adcock IM, Brown CR, Kwon O, et al: Oxidative stress induces NFκB DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun 1994; 199:1518-1524
96. Abraham E: NF-kappa B activation. Crit Care Med 2000; 28:N100-N104
97. Aston K, Rath N, Naik A, et al: Computer-aided design (CAD) of Mn(II) complexes: Superoxide dismutase mimetics with catalytic activity exceeding the native enzyme. Inorg Chern 2001; 40:1779-1789
98. Szabo C, Hasko G, Zingarelli B, et al: Isoproterenol regulates tumor necrosis factor, interleukin-10, interleukin-6, and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxemia. Immunology 1997; 90:95-100
99. Gornikiewicz A, Sautner T, Brostjan C, et al: Catecholamines up-regulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells. FASEB J 2000; 14:1093-1100
100. Graham DG: Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 1978; 14:633-643
101. Bindoli A, Deeble DJ, Rigobello MP, et al: Direct and respiratory chain-mediated redox cycling of adrenochrome. Biochim Biophys Acta 1990; 1016:349-356
102. Singal PK, Dhillon RE, Beamish RE, et al: Myocardial cell damage and cardiovascular changes due to iv infusion of adrenochrome in rats. J Exp Pathol 1982; 63:167-175
103. Matthews SB, Hallett MB, Henderson AH, et al: The adrenochrome pathway: A potential catabolic route for adrenaline metabolism in inflammatory disease. Adv Myocardiol 1985; 6:367-381
104. Macarthur H, Salvemini D, Westfall TC: Peroxynitrite is involved in the development of hyporeactivity to norepinephrine in endotoxemia. FASEB J 1999; 13:A757-A748
105. Szabo C, Salzman AL, Ischiropoulos H: Endotoxin triggers the expression of an inducible isoform of NO synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett 1995; 363:235-238
106. Stern MK, Jensen MP, Kramer K: Peroxynitrite decomposition catalysts. J Am Chem Soc 1996; 118:8735
107. Salvemini D, Wang ZQ, Stern MK, et al: Peroxynitrite decomposition catalysts: Therapeutics for peroxynitrite-mediated pathology. Proc Natl Acad Sci U S A 1998; 95:2659-2663
108. Misko TP, Highkin MK, Veenhuizen AW, et al: Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J Biol Chem 1998; 273:15646-15653
109. Szabo C: The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996; 6:79-88
110. Cuzzocrea S, Riley DP, Caputi AP, et al: Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001; 53:135-159
111. Lefer AM: Physiologic and pathophysiologic role of cyclo-oxygenase metabolites of arachidonic acid in circulatory disease states. Cardiovasc Clin 1987; 18:85-99
112. Lefer AM, Tsao PS, Lefer DJ, et al: Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 1991; 5:2029-2034
113. Mccord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312:159-163
114. Gianello P, Saliez A, Bufkens X, et al: EUK-134, a synthetic superoxide dismutase and catalase mimetic, protects rat kidneys from ischemia-reperfusion-induced damage. Transplantation 1996; 62:1664-1666
115. Pucheu S, Boucher F, Sulpice T, et al: EUK-8 a synthetic catalytic scavenger of reactive oxygen species protects isolated iron-overloaded rat heart from functional and structural damage induced by ischemia/reperfusion. Cardiovasc Drugs Ther 1996; 10:331-339
116. Tanguy S, Boucher FR, Malfroy B, et al: Free radicals in reperfusion-induced arrhythmias: Study with EUK 8, a novel non-protein catalytic antioxidant. Free Radic Biol Med 1996; 21:945-954
117. Masini E, Cuzzocrea S, Mazzon E, et al: Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo. Br J Pharmacol 2002; 136:905-917
118. Gryglewski RJ, Palmer RM, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320:454-456
119. Matheis G, Sherman MP, Buckberg GD, et al: Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992; 262:H616-H620
120. Wang P, Zweier JL: Measurement of nitric oxide and peroxynitrite generation in the postischemic heart: Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem 1996; 15:29223-29230
121. Ma TT, Ischiropoulos H, Brass CA: Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology 1995; 108:463-469
122. Yu L, Gengaro PE, Niederberger M, et al: Nitric oxide: A mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci U S A 1994; 91:1691-1695
123. Cuzzocrea S, Zingarelli B, Costantino G, et al: Beneficial effects of 3-aminobenzamide, an inhibitor of Poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharrnacol 1997; 121:1065-1074
124. Szabo C, Salzman AL, Ischiropoulos H: Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett 1995; 372:229-232
125. Cazevieille C, Muller A, Meynier F, et al: Superoxide and nitric oxide cooperation in hypoxia/reoxigenation-induced neuron injury. Free Radical Biol Meal 1993; 14:389-395
126. Ischiropoulos H, al-Mehdi AB, Fisher AB: Reactive species in ischemic rat lung injury: Contribution of peroxynitrite. Am J Physiol 1995; 269:L158-L164
127. Beckman JS, Beckman TW, Chen J, et al: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990; 87:1620-1624
128. Ischiropoulos H, Zhu L, Chen J, et al: Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992; 298:431-437
129. Crow JP, Beckman JS: Reactions between nitric oxide, superoxide, and peroxynitrite: Footprints of peroxynitrite in vivo. Adv Pharmacol 1995; 34:17-43
130. Salvemini D, Jensen MP, Riley DP, et al: Therapeutic manipulations of peroxynitrite. Drug News Perspect 1998; 11:204-214
131. Salvemini D, Wang ZQ, Bourdon DM, et al: Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema. Eur J Pharmacol 1996; 303:217-220
132. Ferdinandy P, Danial H, Ambrus I, et al: Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 2000; 87:241-247
133. Cuzzocrea S, Misko TP, Costantino G, et al: Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J 2000; 14:1061-1072
134. Beckman JS: Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996; 9:836-844
135. Kooy NW, Lewis SJ, Royall JA, et al: Extensive tyrosine nitration in human myocardial inflammation: Evidence for the presence of peroxynitrite. Crit Care Med 1997; 25:812-819
136. Mihm MJ, Yu F, Carnes CA, et al: Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001; 104:174-180
137. Mihm MJ, Coyle CM, Schanbacher BL, et al: Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc Res 2001; 49:798-807
138. Cuzzocrea S, Mazzon E, Dugo L, et al: Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis. Eur J Pharmacol 2001; 432:79-89
139. Cuzzocrea S, Zingarelli B, Gilard E, et al: Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in carrageenan-induced models of local inflammation. Eur J Pharmacol 1998; 342:67-76
140. Szabó C, Lim LHK, Cuzzocrea S, et al: Inhibition of poly (ADP-ribose) synthetase exerts anti-inflammatory effects and inhibits neutrophil recruitment. J Exp Med 1997; 186:1041-1049
141. Szabo G, Bahrle S, Stumpf N, et al: Poly-(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res 2002; 90:100-106
142. Wayman N, McDonald MC, Thompson AS, et al: 5-aminoisoquinolinone, a potent inhibitor of poly (adenosine 5′-diphosphate ribose) polymerase, reduces myocardial infarct size. Eur J Pharmacol 2001; 430:93-100
143. Thiemermann C: Inhibition of the activity of poly (ADP-ribose) polymerase in ischemia-reperfusion injury. Shock 2000; 14:142-143
144. Zingarelli B, Salzman AL, Szabo C: Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 1998; 83:85-94
145. McInnis J, Wang C, Anastasio N, et al: The role of superoxide and nuclear factor-kappaB signaling in N-methyl-D-aspartate-induced necrosis and apoptosis. J Pharmacol Exp Ther 2002; 301:478-487
146. Lowe D, Pagel PS, Mcgough MF, et al: Comparison of the cardiovascular effects of two novel superoxide dismutase mimetics, SC-55858 and SC-54417, in conscious dogs. Eur J Pharmacol 1996; 304:81-86
147. Geng JG, Bevilacqua MP, Moore KL, et al: Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990; 343:757-760
148. Dreyer WJ, Michael LH, West MS, et al: Neutrophil accumulation in ischemic canine myocardium: Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 1991; 84:400-411
149. Farhood A, Mcguire GM, Manning AM, et al: Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leukoc Biol 1995; 57:368-374
150. Shreeniwas R, Koga S, Karakurum M, et al: Hypoxia-mediated induction of endothelial cell interleukin-1 alpha: An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest 1992; 90:2333-2339
151. Matata BM, Galinanes M: Peroxynitrite is an essential component of cytokine production mechanism in human monocytes through modulation of NF-(kappa)B DNA-binding activity. J Biol Chem 2002; 277:2330-2335